Verastem (VSTM) Cash & Current Investments (2011 - 2026)

Verastem (VSTM) recorded quarterly Cash & Current Investments of $181.7 million in Q1 2026, down 11.37% quarter-over-quarter from $205.0 million in Q4 2025, and up 54.53% on a YoY basis from $117.6 million in Q1 2025.

Verastem (VSTM) Cash & Current Investments (2011 - 2026) Analysis & Trends

Verastem's Cash & Current Investments history runs 16 years deep, the most recent figure standing at $181.7 million for Q1 2026.

  • In Q1 2026, Cash & Current Investments rose 54.53% year-over-year to $181.7 million; the TTM figure through Mar 2026 stood at $181.7 million (up 54.53% YoY), while the FY2025 annual figure was $205.0 million, up 130.8% from the prior year.
  • Cash & Current Investments was $181.7 million for Q1 2026 at Verastem, down from $205.0 million in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $205.0 million in Q4 2025 to a low of $83.4 million in Q2 2024.
  • Historically, Cash & Current Investments has averaged $129.1 million across 5 years, with a median of $113.2 million in 2024.
  • The sharpest annual moves came in 2024 and 2025: Cash & Current Investments slumped 54.46% in 2024, then surged 130.8% in 2025.
  • A 5-year view of Cash & Current Investments shows it stood at $92.0 million in 2022, then soared by 48.99% to $137.1 million in 2023, then slumped by 35.23% to $88.8 million in 2024, then soared by 130.8% to $205.0 million in 2025, then fell by 11.37% to $181.7 million in 2026.
  • The last three Cash & Current Investments figures came in at $181.7 million (Q1 2026), $205.0 million (Q4 2025), and $137.7 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 32.30 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 2.13 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 286.70 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 18.44 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 2.77 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 7.20 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 7.25 Bn
9 Abivax 91.96 Bn 91.96 Bn - -
10 Verastem 407.42 Mn 225.74 Mn 15.90 Mn 181.68 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 181.68 Mn
Dec 31, 2025 204.99 Mn
Sep 30, 2025 137.71 Mn
Jun 30, 2025 164.32 Mn
Mar 31, 2025 117.57 Mn
Dec 31, 2024 88.82 Mn
Sep 30, 2024 113.18 Mn
Jun 30, 2024 83.37 Mn
Mar 31, 2024 110.13 Mn
Dec 31, 2023 137.13 Mn
Sep 30, 2023 165.66 Mn
Jun 30, 2023 183.09 Mn
Mar 31, 2023 111.20 Mn
Dec 31, 2022 92.04 Mn
Sep 30, 2022 103.98 Mn
Jun 30, 2022 94.31 Mn
Mar 31, 2022 106.28 Mn
Dec 31, 2021 153.80 Mn
Sep 30, 2021 103.42 Mn
Jun 30, 2021 108.14 Mn